The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementing geriatric assessment for dose optimization of CDK 4/6 inhibitors in older breast cancer patients (IMPORTANT trial): A pragmatic randomized-controlled trial.
 
Antonios Valachis
No Relationships to Disclose
 
Laura Biganzoli
Honoraria - Boehringer Ingelheim; Exact Sciences; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Genomic Health; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen
Research Funding - Celgene (Inst); Genomic Health (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo
 
Athina Christopoulou
No Relationships to Disclose
 
Kamilla Fjermeros
No Relationships to Disclose
 
Eleni Fountzila
No Relationships to Disclose
 
Jürgen Geisler
No Relationships to Disclose
 
Raquel Gomez-Bravo
No Relationships to Disclose
 
Peeter Karihtala
Consulting or Advisory Role - Lilly; Novartis; Pfizer
 
Paris A. Kosmidis
No Relationships to Disclose
 
Angelos Koutras
No Relationships to Disclose
 
Helena Linardou
No Relationships to Disclose
 
Henrik Lindman
Honoraria - AstraZeneca; Daiichi Sankyo; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Medac; MSD Oncology; Novartis; Pierre Fabre; Seagen
Research Funding - Roche (Inst)
 
Icro Meattini
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Seagen
 
Montserrat Muñoz
Consulting or Advisory Role - Seagen
Speakers' Bureau - Esteve; Gilead Sciences; Gilead Sciences; Gilead Sciences; Roche; Roche
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Lilly; Pfizer; Roche; Roche; Roche
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
Emanuela Risi
No Relationships to Disclose
 
Aglaia Schiza
No Relationships to Disclose
 
Meri Utriainen
No Relationships to Disclose
 
Luca Visani
No Relationships to Disclose
 
Thanos Kosmidis
No Relationships to Disclose